Radiomics
    Insight-based
    decision making

    Diseases and
    therapeutic areas

    Discover
    where we are active

    Industry
    and Pharma

    Discover
    our services

    Healthcare
    professionals

    Discover
    our products

    Scientific
    researchers

    Discover
    our expertise

    About Radiomics

    Radiomics is a next generation Liege-based imaging CRO built upon the unparallel experience of its founders, pioneers of the radiomics science.

    Radiomics focuses on AI powered healthcare, with a unique expertise in Radiomics, Deep Learning & Federated Learning applied to oncology and other therapeutic areas. Through our proprietary advanced image analysis technology, we aim to unravel the gold mine of hidden data information embedded in standard medical images.

    Our final goal is to support insight-based decision making for optimizing pharmaceutical and biotech companies’ clinical trials and drug development studies and for providing clinicians with a patient-centered approach based on personalized medicine. With this aim, Radiomics’ R&D team is continuously working on new solutions, in collaboration with multiple national and international partners.
    Read more

    We can help you

    optimize

    Optimize

    Your clinical trials (in terms of casts and time)
    detect

    Detect

    The subtlest signals of drugs efficacy and safety risk
    facilitate

    Facilitate

    Your crucial
    go / no-go
    decisions
    identify

    Identify

    Patients likely to respond to your treatment
    strenghten

    Strenghten

    Your points
    in pay for outcome scenarios

    Why Radiomics

    Experience

    Our scientists and clinicians are the ones who invented radiomics and have unparalleled experience and international recognition in this AI field.

    Outreach

    Radiomics has clients and partners in the EU, the US, Africa and Australia. Permanent presence in North America and China are in our plans for the near future.

    IP Portfolio

    Radiomics' comprehensive IP portfolio includes both granted and pending international (EU/US) patents.

    People

    Radiomics' team is composed of a multicultural and multidisciplinary set of people, specialized in a broad range of domains always enthusiastic in addressing clients and partner's needs. 

    Publications

    Radiomics has numerous publications in high impact journals such as Nature Reviews, Clinical Oncology, Annals of Oncology and many more. 

    Latest news

    • May 19th, 2021

    Visite de Mathieu Michel, Secrétaire d’Etat à la Digitalisation

    La société Radiomics est heureuse et fière d’annoncer la visite, ce 19 mai 2021, de Monsieur Mathieu Michel, Secrétaire d’Etat fédéral belge à la Digitalisation, chargé de la Simplification administrative, de la Protection de la vie privée et de la Régie des Bâtiments.

    Read more
    • May 3rd, 2021

    Radiomics Opens its first North American office in Toronto, Ontario

    Radiomics is pleased to announce the official opening of its first North American sales and support office with the support of the Walloon investment support agency AWEX. The new office, established in Toronto, Ontario will kick-start the company's partnerships in the area, better accommodating pharma companies and clinicians’ needs through North America-based team members.

    Read more
    • April 20th, 2021

    Radiomics CEO Wim Vos guest at Tekna Talks

    Wim Vos CEO of Radiomics guest at Tekna Talks: Drug discovery – from airflow around a bobsleigh to airflow in the lungs.

    Read more
    Read our latest news
    Share this page with your network
    radiomics logo
    Go to
    diseases and therapeutic areas
    industry & pharma
    healthcare professionals
    scientific researchers & academia
    Contact
    Clos Chanmurly 13
    4000 Liège
    Belgium
    BE.0662.719.440
    info@radiomics.bio
    Design:Nelson